Search

Your search keyword '"Hasle, Henrik"' showing total 22 results

Search Constraints

Start Over You searched for: Author "Hasle, Henrik" Remove constraint Author: "Hasle, Henrik" Topic acute myeloid leukaemia Remove constraint Topic: acute myeloid leukaemia
22 results on '"Hasle, Henrik"'

Search Results

1. Characteristics and outcome of primary resistant disease in paediatric acute myeloid leukaemia.

2. Fusion transcript analysis reveals slower response kinetics than multiparameter flow cytometry in childhood acute myeloid leukaemia.

3. Peripheral blood molecular measurable residual disease is sufficient to identify patients with acute myeloid leukaemia with imminent clinical relapse.

4. Measurable residual disease assessment by qPCR in peripheral blood is an informative tool for disease surveillance in childhood acute myeloid leukaemia.

5. Complex and monosomal karyotype are distinct cytogenetic entities with an adverse prognostic impact in paediatric acute myeloid leukaemia. A NOPHO‐DBH‐AML study.

6. Outcome after intensive reinduction therapy and allogeneic stem cell transplant in paediatric relapsed acute myeloid leukaemia.

7. Hyperleucocytosis in paediatric acute myeloid leukaemia - the challenge of white blood cell counts above 200 × 109/l. The NOPHO experience 1984-2014.

8. Strategies for reducing the treatment-related physical burden of childhood acute myeloid leukaemia - a review.

9. Residual disease detected by flow cytometry is an independent predictor of survival in childhood acute myeloid leukaemia; results of the NOPHO- AML 2004 study.

10. The applicability of the WHO classification in paediatric AML. A NOPHO- AML study.

11. A critical review of which children with acute myeloid leukaemia need stem cell procedures.

12. A novel RT-q PCR assay for quantification of the MLL- MLLT3 fusion transcript in acute myeloid leukaemia.

13. Outcome of poor response paediatric AML using early SCT.

14. Treatment-related deaths in second complete remission in childhood acute myeloid leukaemia.

15. Early and treatment-related deaths in childhood acute myeloid leukaemia in the Nordic countries: 1984-2003.

16. Salvage treatment for children with refractory first or second relapse of acute myeloid leukaemia with gemtuzumab ozogamicin: results of a phase II study.

17. Relapse prediction in acute myeloid leukaemia patients in complete remission using WT1 as a molecular marker: development of a mathematical model to predict time from molecular to clinical relapse and define optimal sampling intervals.

18. Improved outcome after relapse in children with acute myeloid leukaemia.

19. Acute leukaemia in children with Down syndrome: a population-based Nordic study.

20. Treatment stratification based on initial in vivo response in acute myeloid leukaemia in children without Down's syndrome: results of NOPHO-AML trials.

21. Musculoskeletal Symptoms and Misdiagnoses in Children With Acute Myeloid Leukaemia: A Nationwide Cohort Study.

22. A population-based study of childhood myelodysplastic syndrome in British Columbia, Canada.

Catalog

Books, media, physical & digital resources